SARS-CoV-2 nosocomial infection acquired in a French university hospital during the 1st wave of the Covid-19 pandemic, a prospective study.
A LandoasF CazzorlaM GalloucheS LarratB NemozC GinerM Le MaréchalP PaveseO EpaulardP MorandM-R MallaretCaroline LandellePublished in: Antimicrobial resistance and infection control (2021)
The number of nosocomial COVID-19 cases in our hospital was low. Compliance regarding mask wearing, hand hygiene and lockdown measures drastically reduced transmission of the virus. Monitoring of nosocomial COVID-19 cases during the first wave enabled us to determine to what extent the hygiene measures taken were effective and patients protected. Trial registration Study ethics approval was obtained retrospectively on 30 September 2020 (CECIC Rhône-Alpes-Auvergne, Clermont-Ferrand, IRB 5891).
Keyphrases
- sars cov
- coronavirus disease
- acinetobacter baumannii
- end stage renal disease
- respiratory syndrome coronavirus
- methicillin resistant staphylococcus aureus
- klebsiella pneumoniae
- ejection fraction
- chronic kidney disease
- newly diagnosed
- public health
- healthcare
- clinical trial
- prognostic factors
- study protocol
- randomized controlled trial
- drug resistant
- multidrug resistant
- phase iii
- pseudomonas aeruginosa
- big data
- acute care
- oral health
- cystic fibrosis
- patient reported
- open label